Dear E, The biotech capital market has been a rollercoaster ride for the last couple of years, to put it mildly. Now, months after a mid-summer meltdown, where has the dust settled? We'll look at how stakeholders are thinking about investment and financing amid a sector-wide shakeup. Join us at Fierce JPM Week on January 10, 2023 at the Fairmont in San Francisco as we take a deep dive into these issues and industry trends to watch in 2023 . Hear from senior industry leaders at Andreessen Horowitz, Third Rock, PwC, Arcus Biosciences, Gilead, Genentech, Novartis, Beigene, Regeneron and more! VIEW THE IN-PERSON AGENDA Save $100 with the current low rate! There are limited passes available at this rate until Dec 23rd. Register now before it's too late. |
